Skip to main content

Biodegradation of Trimethoprim by a Bacterial Consortium Enriched from a Sewage Treatment Plant

Author(s): Tristan Nilsson 1 , Bliss Broussard 1 , Darcey Wayment 2 , Himanshu Raje 1 ORCID https://orcid.org/0000-0003-0640-2388 , Ramaraj Boopathy 1 , Achmad Syafiuddin 3 ORCID https://orcid.org/0000-0002-4310-7882
Author(s) information:
1 Department of Biological Sciences, Nicholls State University, Thibodaux, Louisiana 70310, United States
2 Department of Chemistry and Physical Sciences, Nicholls State University, Thibodaux, Louisiana 70310, United States
3 Center for Industrial and Environmental Health Studies, Universitas Indonesia, 12345 Depok, Indonesia

Corresponding author

Antibiotic resistance is a persistent public health concern. The excessive use of prescription antibiotics in medical and animal husbandry practices has resulted in potentially harmful levels of antibiotic residues in the environment. Antibiotics released through excreta and industrial effluents exert selective pressure on environmental bacteria, promoting the proliferation and accumulation of antibiotic-resistant bacteria. Diverse microbial communities exhibiting antibiotic resistance may also serve as effective antibiotic degraders. Sewage treatment plants are among the environments most conducive to the development of microbial communities capable of degrading antibiotics. This study focused on Louisiana because it ranks among the five U.S. states with the highest antibiotic use. Trimethoprim (TMP) is one of the commonly prescribed antibiotics. The purpose of this study was to investigate the presence of TMP-degrading microbial communities in a small community sewage treatment plant. Sludge was collected from the anaerobic digester at the Thibodaux sewage treatment plant, and a microbial consortium was subsequently enriched. The consortium was cultivated with TMP under various growth conditions. TMP degradation was analyzed using high-performance liquid chromatography and mass spectrometry. The results showed that the consortium was capable of degrading TMP under co-metabolic conditions, with 4-desmethyl trimethoprim identified as a major metabolite. The dfrA12 and dfrA5 genes, which are associated with TMP resistance, were detected in DNA isolated from the consortium.

Next article

Mulchandani, R.; et al. (2025). Global trends in inappropriate use of antibiotics, 2000–2021: scoping review and prevalence estimates. BMJ Public Health, 3, e002411. https://doi.org/10.1136/bmjph-2024-002411.

Klein, E.Y.; et al. (2018). Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proceedings of the National Academy of Sciences of the United States of America, 115, E3463‒E3470. https://doi.org/10.1073/pnas.1717295115.

Baquero, F.; Lanza, V.F.; Cantón, R.; Coque, T.M. (2015). Public health evolutionary biology of antimicrobial resistance: priorities for intervention. Evolutionary Applications, 8, 223‒239. https://doi.org/10.1111/eva.12235.

Gullberg, E.; et al. (2011). Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathogens, 7, e1002158. https://doi.org/10.1371/journal.ppat.1002158.

Tao, S.; Chen, H.; Li, N.; Wang, T.; Liang, W. (2022). The Spread of Antibiotic Resistance Genes In Vivo Model. Canadian Journal of Infectious Diseases and Medical Microbiology, 2022, 3348695. https://doi.org/10.1155/2022/3348695.

Kemnic, T.R.; Coleman, M. (2026). Trimethoprim Sulfamethoxazole. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA. (accessed on 11 May 2026) Available online: http://www.ncbi.nlm.nih.gov/books/NBK513232/.

Outpatient Antibiotic Prescriptions — United States, 2017 | Antibiotic Use | CDC. (accessed on 11 May 2026) Available online: https://archive.cdc.gov/www_cdc_gov/antibiotic-use/data/report-2017.html.

Gleckman, R.; Blagg, N.; Joubert, D.W. (1981). Trimethoprim: Mechanisms of Action, Antimicrobial Activity, Bacterial Resistance, Pharmacokinetics, Adverse Reactions, and Therapeutic Indications. Pharmacotherapy, 1, 14‒19. https://doi.org/10.1002/j.1875-9114.1981.tb03548.x.

Liu, C.T.; Hanoian, P.; French, J.B.; Pringle, T.H.; Hammes-Schiffer, S.; Benkovic, S.J. (2013). Functional significance of evolving protein sequence in dihydrofolate reductase from bacteria to humans. Proceedings of the National Academy of Sciences of the United States of America, 110, 10159‒10164. https://doi.org/10.1073/pnas.1307130110.

Toulouse, J.L.; Edens, T.J.; Alejaldre, L.; Manges, A.R.; Pelletier, J.N. (2017). Integron-Associated DfrB4, a Previously Uncharacterized Member of the Trimethoprim-Resistant Dihydrofolate Reductase B Family, Is a Clinically Identified Emergent Source of Antibiotic Resistance. Antimicrobial Agents and Chemotherapy, 61, e02665-16. https://doi.org/10.1128/AAC.02665-16.

Grape, M.; Farra, A.; Kronvall, G.; Sundström, L. (2005). Integrons and gene cassettes in clinical isolates of co-trimoxazole-resistant Gram-negative bacteria. Clinical Microbiology and Infection, 11, 185‒192. https://doi.org/10.1111/j.1469-0691.2004.01059.x.

Sánchez-Osuna, M.; Cortés, P.; Llagostera, M.; Barbé, J.; Erill, I. (2020). Exploration into the origins and mobilization of di-hydrofolate reductase genes and the emergence of clinical resistance to trimethoprim. Microbial Genomics, 6, mgen000440. https://doi.org/10.1099/mgen.0.000440.

Toulouse, J.L.; et al. (2020). Dual-Target Inhibitors of the Folate Pathway Inhibit Intrinsically Trimethoprim-Resistant DfrB Dihydrofolate Reductases. ACS Medicinal Chemistry Letters, 11, 2261‒2267. https://doi.org/10.1021/acsmedchemlett.0c00393.

Jewell, K.S.; Castronovo, S.; Wick, A.; Falås, P.; Joss, A.; Ternes, T.A. (2016). New insights into the transformation of trimethoprim during biological wastewater treatment. Water Research, 88, 550‒557. https://doi.org/10.1016/j.watres.2015.10.026.

Luo, X.; Zheng, Z.; Greaves, J.; Cooper, W.J.; Song, W. (2012). Trimethoprim: Kinetic and mechanistic considerations in photochemical environmental fate and AOP treatment. Water Research, 46, 1327‒1336. https://doi.org/10.1016/j.watres.2011.12.052.

Joss, A.; et al. (2006). Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification scheme. Water Research, 40, 1686‒1696. https://doi.org/10.1016/j.watres.2006.02.014.

Guo, J.; et al. (2017). Unraveling microbial structure and diversity of activated sludge in a full-scale simultaneous nitrogen and phosphorus removal plant using metagenomic sequencing. Enzyme and Microbial Technology, 102, 16‒25. https://doi.org/10.1016/j.enzmictec.2017.03.009.

Mayhew, M.; Stephenson, T. (1997). Low Biomass Yield Activated Sludge: A Review. Environmental Technology, 18, 883‒892. https://doi.org/10.1080/09593331808616607.

Igoni, A.H.; Abowei, M.F.N.; Ayotamuno, M.J.; Eze, C.L. (2008). Effect of Total Solids Concentration of Municipal Solid Waste on the Biogas Produced in an Anaerobic Continuous Digester. Agricultural Engineering International: CIGR Journal. (accessed on 11 May 2026) Available online: https://cigrjournal.org/index.php/Ejounral/article/view/1288.

Matheri, A.N.; Nabadda, E.; Mohamed, B. (2023). Sustainable and circularity in the decentralized hybrid solar-bioenergy system. Environment, Development and Sustainability, 26, 16987‒17011. https://doi.org/10.1007/s10668-023-03322-w.

Tang, M.; et al. (2020). Enhanced hydrolysis of fermentative antibiotics in production wastewater: Hydrolysis potential prediction and engineering application. Chemical Engineering Journal, 391, 123626. https://doi.org/10.1016/j.cej.2019.123626.

Naquin, A.; Shrestha, A.; Sherpa, M.; Nathaniel, R.; Boopathy, R. (2015). Presence of antibiotic resistance genes in a sewage treatment plant in Thibodaux, Louisiana, USA. Bioresource Technology, 188, 79‒83. https://doi.org/10.1016/j.biortech.2015.01.052.

Arceneaux, E.; Nathaniel, K.; Pinel, C.; Cortez, T.; Boopathy, R. (2025). Performance of a Constructed Wetland in Reducing Nutrients, Fecal Coliform Bacteria, and Antibiotic Resistant Bacteria. Environmental Quality Management, 35, e70117. https://doi.org/10.1002/tqem.70117.

Styszko, K.; et al. (2025). Tracking nonregulated micropollutants in sewage sludge: Antimicrobials, OH-PAHs, and microplastics — Environmental risks, fertilizer implications and energy considerations. Energy Reports, 13, 4756‒4768. https://doi.org/10.1016/j.egyr.2025.04.013.

Horvath, R.S. (1972). Microbial co-metabolism and the degradation of organic compounds in nature. Bacteriological Reviews, 36, 146‒155. https://doi.org/10.1128/br.36.2.146-155.1972.

Chi, Z.; et al. (2023). Co-metabolic biodegradation of chlorinated ethene in an oxygen- and ethane-based membrane biofilm reactor. Science of the Total Environment, 905, 167323. https://doi.org/10.1016/j.scitotenv.2023.167323.

Fischer, K.; Majewsky, M. (2014). Cometabolic degradation of organic wastewater micropollutants by activated sludge and sludge-inherent microorganisms. Applied Microbiology and Biotechnology, 98, 6583‒6597. https://doi.org/10.1007/s00253-014-5826-0.

Feng, N.-X.; et al. (2019). Co-metabolic degradation of the antibiotic ciprofloxacin by the enriched bacterial consortium XG and its bacterial community composition. Science of the Total Environment, 665, 41‒51. https://doi.org/10.1016/j.scitotenv.2019.01.322.

Jiang, M.; et al. (2023). Ampicillin-controlled glucose metabolism manipulates the transition from tolerance to resistance in bacteria. Science Advances, 9, eade8582. https://doi.org/10.1126/sciadv.ade8582.

De Araujo, C.A.V.; et al. (2017). Simultaneous Removal of the Antimicrobial Activity and Toxicity of Sulfamethoxazole and Trimethoprim by White Rot Fungi. Water, Air, & Soil Pollution, 228, 341. https://doi.org/10.1007/s11270-017-3525-z.

Rodrigues, D.A.D.S.; da Cunha, C.C.R.F.; Pereira, A.R.; Espírito Santo, D.R.D.; Silva, S.Q.; Starling, M.C.V.M.; Santiago, A.D.F.; Afonso, R.J.C.F. (2025). Biodegradation of trimethoprim and sulfamethoxazole in secondary effluent by microalgae-bacteria consortium. International Journal of Hygiene and Environmental Health, 264, 114517. https://doi.org/10.1016/j.ijheh.2024.114517.

Tay, S.T.-L. (2006). Removal of phenol from wastewater by microbial granules. In Waste Management Series, Vol. 6; Elsevier: Amsterdam, The Netherlands; pp. 191‒IV. https://doi.org/10.1016/S0713-2743(06)80111-X.

Carneiro, R.B.; Sabatini, C.A.; Titato, G.M.; Ferreira, T.C.R.; Zaiat, M.; Santos-Neto, Á.J. (2022). New biotransformation pathways from sulfamethoxazole and ciprofloxacin removal in sewage treatment along the spatial profile of an anaerobic fixed bed bioreactor. Bioresource Technology Reports, 17, 100944. https://doi.org/10.1016/j.biteb.2022.100944.

Xu, T.; et al. (2025). Prediction of hydrolysis pathways and kinetics of sulfamethoxazole: A machine-learning-based molecular dynamics and experimental study. Journal of Hazardous Materials, 494, 138429. https://doi.org/10.1016/j.jhazmat.2025.138429.

Bergan, T.; Carlsen, I.B. (1985). Effect of antibiotics eliminated by first order kinetics. Journal of Antimicrobial Chemotherapy, 15, 147‒152. https://doi.org/10.1093/jac/15.suppl_A.147.

Tsoi, R.; Wu, F.; Zhang, C.; Bewick, S.; Karig, D.; You, L. (2018). Metabolic division of labor in microbial systems. Proceedings of the National Academy of Sciences of the United States of America, 115, 2526‒2531. https://doi.org/10.1073/pnas.1716888115.

Saati-Santamaría, Z.; Navarro-Gómez, P.; Martínez-Mancebo, J.A.; Juárez-Mugarza, M.; Flores, A.; Canosa, I. (2025). Genetic and species rearrangements in microbial consortia impact biodegradation potential. The ISME Journal, 19, wraf014. https://doi.org/10.1093/ismejo/wraf014.

Wang, X.; et al. (2025). Efficient anaerobic biodegradation of trimethoprim driven by electrogenic respiration: Optimizing bioelectro-characterization, elucidating biodegradation mechanism and fate of antibiotic resistance genes systematically. Journal of Hazardous Materials, 492, 138070. https://doi.org/10.1016/j.jhazmat.2025.138070.

Liang, B.; Kong, D.; Qi, M.; et al. (2019). Anaerobic biodegradation of trimethoprim with sulfate as an electron acceptor. Frontiers of Environmental Science & Engineering, 13, 84. https://doi.org/10.1007/s11783-019-1168-6.

Ndlela, L.L.; Schroeder, P.; Genthe, B.; Cruzeiro, C. (2023). Removal of Antibiotics Using an Algae-Algae Consortium (Chlorella protothecoides and Chlorella vulgaris). Toxics, 11, 588. https://doi.org/10.3390/toxics11070588

Zhang, T.; Zhang, H. (2022). Microbial Consortia Are Needed to Degrade Soil Pollutants. Microorganisms, 10, 261. https://doi.org/10.3390/microorganisms10020261.

About this article

SUBMITTED: 06 August 2026
ACCEPTED: 28 September 2026
PUBLISHED: 13 October 2026
SUBMITTED to ACCEPTED: 53 days
DOI: https://doi.org/10.53623/erph.v2i2.1327

Cite this article
Nilsson, T. ., Broussard, B. ., Wayment, D. ., Raje, H. ., Boopathy, R. ., & Syafiuddin, A. (2026). Biodegradation of Trimethoprim by a Bacterial Consortium Enriched from a Sewage Treatment Plant. Environmental Research and Planetary Health, 2(2), 123–135. https://doi.org/10.53623/erph.v2i2.1327
Citations
0
Share this article